Kumar S, Duncan G
Mol Ther Nucleic Acids. 2024; 35(4):102393.
PMID: 39687340
PMC: 11647486.
DOI: 10.1016/j.omtn.2024.102393.
Plasschaert L, MacDonald K, Moffit J
Front Pharmacol. 2024; 15:1476331.
PMID: 39439894
PMC: 11493704.
DOI: 10.3389/fphar.2024.1476331.
Abou Alaiwa M, Hilkin B, Price M, Gansemer N, Rector M, Stroik M
bioRxiv. 2024; .
PMID: 39229081
PMC: 11370470.
DOI: 10.1101/2024.05.22.594822.
Stoltz D
Trans Am Clin Climatol Assoc. 2024; 134:29-36.
PMID: 39135587
PMC: 11316882.
Stewart C, Hilkin B, Gansemer N, Adam R, Dick D, Sunderland J
Am J Physiol Lung Cell Mol Physiol. 2024; 327(4):L415-L422.
PMID: 39104314
PMC: 11482522.
DOI: 10.1152/ajplung.00010.2024.
Cystic fibrosis patient characteristics and healthcare resource utilization in Finland using linked registries.
Malmivaara K, Polkki M, Prami T, Raittinen P, Heikkila E, Aalto A
Heliyon. 2024; 10(13):e33439.
PMID: 39040318
PMC: 11261030.
DOI: 10.1016/j.heliyon.2024.e33439.
Growing from common ground: nontuberculous mycobacteria and bronchiectasis.
Van Braeckel E, Bosteels C
Eur Respir Rev. 2024; 33(173).
PMID: 38960614
PMC: 11220627.
DOI: 10.1183/16000617.0058-2024.
Epithelial responses to CFTR modulators are improved by inflammatory cytokines and impaired by antiinflammatory drugs.
Rehman T, Pezzulo A, Thurman A, Zemans R, Welsh M
JCI Insight. 2024; 9(14.
PMID: 38888974
PMC: 11383177.
DOI: 10.1172/jci.insight.181836.
Bone-organ axes: bidirectional crosstalk.
Deng A, Wang F, Wang S, Zhang Y, Bai L, Su J
Mil Med Res. 2024; 11(1):37.
PMID: 38867330
PMC: 11167910.
DOI: 10.1186/s40779-024-00540-9.
Heterogeneity of CFTR modulator-induced sweat chloride concentrations in people with cystic fibrosis.
Zemanick E, Emerman I, McCreary M, Mayer-Hamblett N, Warden M, Odem-Davis K
J Cyst Fibros. 2024; 23(4):676-684.
PMID: 38360461
PMC: 11322419.
DOI: 10.1016/j.jcf.2024.02.001.
Pharmacological Improvement of Cystic Fibrosis Transmembrane Conductance Regulator Function Rescues Airway Epithelial Homeostasis and Host Defense in Children with Cystic Fibrosis.
Loske J, Voller M, Lukassen S, Stahl M, Thurmann L, Seegebarth A
Am J Respir Crit Care Med. 2024; 209(11):1338-1350.
PMID: 38259174
PMC: 11146576.
DOI: 10.1164/rccm.202310-1836OC.
Risk for Dehydration and Fluid and Electrolyte Disorders Among Cystic Fibrosis Carriers.
Lee S, Harris L, Miller A, Cavanaugh J, Nizar J, Simmering J
Am J Kidney Dis. 2023; 83(5):695-697.
PMID: 37951339
PMC: 11068020.
DOI: 10.1053/j.ajkd.2023.09.011.
Identification of cystic fibrosis transmembrane conductance regulator gene (CFTR) variants: A retrospective study on the western and southern regions of Saudi Arabia.
Almaghamsi T, Attiyah W, Bahasan M, Alotaibi B, AlAhmadi S, Hanbazazh M
Saudi Med J. 2023; 44(10):987-994.
PMID: 37777263
PMC: 10541982.
DOI: 10.15537/smj.2023.44.10.20230290.
Inflammatory Activity of Epithelial Stem Cell Variants from Cystic Fibrosis Lungs Is Not Resolved by CFTR Modulators.
Wang S, Niroula S, Hoffman A, Khorrami M, Khorrami M, Yuan F
Am J Respir Crit Care Med. 2023; 208(9):930-943.
PMID: 37695863
PMC: 10870857.
DOI: 10.1164/rccm.202305-0818OC.
Infection, Allergy, and Inflammation: The Role of in Cystic Fibrosis.
Poore T, Zemanick E
Microorganisms. 2023; 11(8).
PMID: 37630573
PMC: 10458351.
DOI: 10.3390/microorganisms11082013.
Genome Editing for Cystic Fibrosis.
Wang G
Cells. 2023; 12(12).
PMID: 37371025
PMC: 10297084.
DOI: 10.3390/cells12121555.
Inflammation as a Regulator of the Airway Surface Liquid pH in Cystic Fibrosis.
Rehman T, Welsh M
Cells. 2023; 12(8).
PMID: 37190013
PMC: 10137218.
DOI: 10.3390/cells12081104.
Drug Hypersensitivity Reactions in Patients with Cystic Fibrosis: Potential Value of the Lymphocyte Toxicity Assay to Assess Risk.
Abuzgaia A, Elzagallaai A, Mullowney T, Rieder M
Mol Diagn Ther. 2023; 27(3):395-403.
PMID: 36939981
DOI: 10.1007/s40291-023-00644-3.
The Role of MMPs in the Era of CFTR Modulators: An Additional Target for Cystic Fibrosis Patients?.
Esposito R, Mirra D, Spaziano G, Panico F, Gallelli L, dAgostino B
Biomolecules. 2023; 13(2).
PMID: 36830719
PMC: 9952876.
DOI: 10.3390/biom13020350.
Gene therapy for cystic fibrosis: Challenges and prospects.
Sui H, Xu X, Su Y, Gong Z, Yao M, Liu X
Front Pharmacol. 2022; 13:1015926.
PMID: 36304167
PMC: 9592762.
DOI: 10.3389/fphar.2022.1015926.
